“Shares of Regeneron are ripping higher Thursday in premarket trading, building on its gains from Wednesday evening, after the company submitted its COVID-19 antibody cocktail to the FDA for emergency-use approval. The news follows President Trump's full-throated endorsement of the therapy, which the president credited for his speedy recovery, calling the treatment a "cure" for COVID-19.”
Read Our Latest News
Do you like this post?
Be the first to comment
Sign in with